Tigo Energy’s Q2 Revenue Growth Slows to 5.6%, Casting Doubt on 2026 Outlook

What happened

Tigo Energy reported Q2 2026 revenue of $25.4 million, a mere 5.6% increase year-over-year, marking a dramatic deceleration from the 89% growth in Q2 2025. This weak print falls well short of the $105–115 million full-year revenue base projected in the investment thesis, implying annualized revenue of only around $100 million. The company provided Q3 and full-year 2026 guidance, but the lack of detail in the release adds uncertainty, particularly around whether gross margins can remain in the 40% range. With EMEA still likely the dominant region, softening demand or pricing pressure there could be eroding Tigo’s core growth engine, exactly the risk flagged in the prior report’s bear scenario. The next earnings call must clarify whether this slowdown is temporary or signals structural deterioration.

Implication

Investors should immediately reassess their positions: the thesis relied on sustained >$100M revenue and 40%+ margins, but Q2’s stalled growth suggests the base case is now at risk. If management’s full-year guidance comes in below $105 million or margins drop, the valuation may fall toward 1x sales or lower, implying a $1.30–$1.50 stock price. The EG4 U.S. partnership and repower theme need to show acceleration in H2 to offset EMEA weakness, but with only 5.6% growth, confidence in that materializing is diminished. The stock now faces a binary outcome: either a strong H2 rebound on new U.S. shipments or a slide into sustained low growth, warranting a defensive positioning. Until more clarity emerges, the attractive entry below $1.80 now looks like a ceiling rather than a floor.

Thesis delta

The prior 'Potential Buy' thesis relied on consistent high growth and margin expansion, but Q2 2026’s anemic revenue increase calls the durability of demand into question. The bull case of $130–140 million revenue for 2026 is virtually unattainable, and even the base case of $105–115 million now appears optimistic without a sharp H2 ramp. Consequently, the thesis shifts from growth at a reasonable price to a show-me story requiring proof of re-acceleration; conviction drops to neutral-to-negative until Q3 and full-year guidance provide clarity.